In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...

For many Tennesseans, biomarker tests are not covered by insurance, which ultimately prevents them from receiving personalized testing and treatment.

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

While it can help with early detection and targeted treatment for Alzheimer's disease, multiple sclerosis and more, it is particularly impactful for cancer patients. Timing is everything when it comes ...

As tests and screenings for chronic conditions improve, Connecticut residents will have better access after lawmakers passed legislation mandating health insurance plans cover biomarker tests starting ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

It may feel nearly impossible to scroll through social media these days without seeing ads for trendy, pricey functional medicine subscription services and at-home tests that promise to unlock key ...

How well a certain treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) works can vary greatly depending on the makeup of an individual patient’s disease, making ...

The company says clinics can save physician time with its new offering by providing patients with tailored, evidence-based ...

September 17, 2009 — Two new related reports provide further evidence of the usefulness of neurophysiological biomarkers in determining the effectiveness of antidepressant medication. The second ...